Nutritis: an ambitious R&D strategy

Based on its innovative design, marketing and technology, Nutritis has developed a particularly ambitious R&D strategy, both in-house and in the context of its partnerships.

Work focuses in parallel on three strategic research areas:


Food, nutrition and health

In partnership with academic research teams, Nutritis is pursuing investigations on the nutritional qualities and functional claims relative to its fruit sugars.

Nutritis Sucre Verre1 FlorenceEdelmann LR 200

The science and Technology of sugars

Nutritis contributes to improving scientific knowledge on fruit sugars as a complex food matrix.  These studies allow Nutritis to guarantee high quality standards for its sugars (in terms of texture, organoleptic profile, sweetening potential, stability, storage) and to provide support for its customers regarding the formulation of their finished products.

Processes and Resources

Nutritis continues to optimise its operations through ongoing developments that notably concern the adaptations necessary to process different fruit resources and the valorisation of by-products.

Nutrition research at Nutritis

"Diseases of civilisation" have now become a real plague in developed, "Westernised" countries and are spreading to other continents through the growth of sedentary lifestyles and changes to eating habits.

Fully aware of this public health issue, and convinced of the positive impact of a dietary approach focused on naturalness, quality and nutritional education, Nutritis is deploying ambitious R&D programmes designed to demonstrate and optimise the nutritional benefits of Fructilight® and FructiSweet®.

Based on clinically validated arguments, the goal targeted by Nutritis is to propose an original range of 100% natural fruit sugars with a low Glycemic Index and high sweetening potential that can reduce the calorie intake and thus supply industrial solutions for the production of foods that reconcile flavour and health.


Download the scientific brochure


In-house research and collaboration with INSERM to characterise the health benefits of fruit sugars

For several years now, Nutritis has been implementing an innovative research programme with INSERM (team led by P. Valet, I2MC Toulouse) in order to characterise the effects of fruit sugars and fructose on regulating and improving blood sugar levels, on satiety, the calorie balance, overweight and the prevention of obesity and diabetes.  The initial results obtained in mice and humans have demonstrated the nutritional value of Nutritis fruit sugars: 1- apple fructose has an extremely low glycemic index (GI = 11.9); 2- insulin secretion linked to its ingestion is very low; 3- at physiological doses, it is even beneficial in maintaining long-term carbohydrate homeostasis, and 4- it exerts neither a hyperglycaemic nor a pre-diabetogenic effect.
Investigations are ongoing in order to determine the molecular mechanisms involved in the specific metabolism of fruit sugars, and to advance further in defining and validating these health benefits.
For more information:
Publication “Native fructose extracted from apple improves glucose tolerance in mice”. J Physiol Biochem, 65 (4), 361-368, 2009.
Publication « Fructose et sucres de fruits: de la nature aux bénéfices nutritionnels ». NAFAS, N°4, Vol 9, Août 2011.
Publication « Index glycémique et fructose de fruits : une spécificité validée ». NAFAS, N°5, Vol 9, Octobre 2011.


The "Fruit FOS" programme

In the context of a pre-competitive, collaborative research project, Nutritis is working on developing the first Fructo-OligoSaccharides (FOS) from fruits within a public-private consortium for excellence which was initiated in 2010 and is led by Nutritis.  This project, which has received funding from the Regional Council (Midi-Pyrénées) and is accredited by two competitiveness clusters (Agrimip Innovation and Cancer-Bio-Santé), focuses on a partnership approach between research and industry and on innovation at the service of territories, sustainable development and public health.
For more information: Cancer-Bio-Health Cluster web site

Suivez-nous sur twitter !